IndexIQ Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-781,328
| Closed | -$715K | – | 640 |
|
|
2018
Q4 | $715K | Sell |
781,328
-184,589
| -19% | -$169K | 0.02% | 451 |
|
|
2018
Q3 | $1.98M | Buy |
965,917
+36,482
| +4% | +$74.7K | 0.06% | 343 |
|
|
2018
Q2 | $1.67M | Sell |
929,435
-7,290
| -0.8% | -$13.1K | 0.05% | 416 |
|
|
2018
Q1 | $2.17M | Buy |
936,725
+470,027
| +101% | +$1.09M | 0.07% | 184 |
|
|
2017
Q4 | $878K | Buy |
466,698
+179,546
| +63% | +$338K | 0.03% | 418 |
|
|
2017
Q3 | $713K | Buy |
287,152
+130,305
| +83% | +$324K | 0.03% | 392 |
|
|
2017
Q2 | $431K | Buy |
+156,847
| New | +$431K | 0.02% | 387 |
|